Company: MDCXW
Filing Date: 2025-05-05
Form Type: 253G2
Source: 0001062993-25-008440
Chunk: 53

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-05
Form: 253G2
Chunk 53
---
 into a global guaranty agreement (the "Guaranty") in favor of Yorkville with respect to the Company's obligations under the Purchase Agreement and the Debentures. Capitalized terms used, but not otherwise defined, herein have the meaning ascribed to such terms in the Purchase Agreement, a copy of which is filed herewith as Exhibit 10.1.

Interest will accrue on the outstanding principal amount of each Debenture at an annual rate of 8.00%, subject to a potential increase to 18.00% per annum upon the occurrence of certain events of default. The Debentures will mature on February 2, 2026 (the "Maturity Date"). The Debentures will be issued at a purchase price equal to 90% of the Subscription Amount. The Company will repay the outstanding principal amount of the Debentures in six equal monthly installments of $500,000 plus accrued and unpaid interest, in cash, as of such payment date starting on the 60-day anniversary of the issuance date of each Debenture (or the outstanding principal amount if the amount owed in the aggregate among all Debentures is less than $500,000), with $2,000,000 (or the remaining outstanding principal amount if the amount owed in the aggregate among all Debentures is less than $2,000,000) plus accrued and unpaid interest due in full on the Maturity Date.

The Debenture provides the Company with an optional redemption right pursuant to which the Company, at any time, may redeem in cash, in whole or in part, all amounts outstanding under the Debentures prior to the Maturity Date. The redemption amount shall be equal to the outstanding principal balance being redeemed by the Company, plus all accrued and unpaid interest in respect of such redeemed principal amount as of such redemption date. Pursuant to the Purchase Agreement, Yorkville may, at any time after the Second Closing, require the Company to redeem all or a portion of the Debentures held by Yorkville at such time with the proceeds of any equity financing undertaken by the Company.

The foregoing descriptions of the Purchase Agreement, Guaranty and Debentures do not purport to be complete and are qualified in their entirety by reference to the full text of such documents, and with respect to the Debentures, a form thereof, which are filed herewith as Exhibits 10.1, 10.2 and 4.1, respectively, and are incorporated herein by reference